FR2304354B1 - - Google Patents

Info

Publication number
FR2304354B1
FR2304354B1 FR7607363A FR7607363A FR2304354B1 FR 2304354 B1 FR2304354 B1 FR 2304354B1 FR 7607363 A FR7607363 A FR 7607363A FR 7607363 A FR7607363 A FR 7607363A FR 2304354 B1 FR2304354 B1 FR 2304354B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7607363A
Other languages
French (fr)
Other versions
FR2304354A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of FR2304354A1 publication Critical patent/FR2304354A1/fr
Application granted granted Critical
Publication of FR2304354B1 publication Critical patent/FR2304354B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7607363A 1975-03-17 1976-03-15 Nouvelles compositions pharmaceutiques a activite retardee Granted FR2304354A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
FR2304354A1 FR2304354A1 (fr) 1976-10-15
FR2304354B1 true FR2304354B1 (cg-RX-API-DMAC7.html) 1979-04-27

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7607363A Granted FR2304354A1 (fr) 1975-03-17 1976-03-15 Nouvelles compositions pharmaceutiques a activite retardee

Country Status (21)

Country Link
JP (1) JPS51115910A (cg-RX-API-DMAC7.html)
AR (1) AR222624A1 (cg-RX-API-DMAC7.html)
AT (1) AT353415B (cg-RX-API-DMAC7.html)
AU (1) AU505355B2 (cg-RX-API-DMAC7.html)
CA (1) CA1073358A (cg-RX-API-DMAC7.html)
CH (1) CH630257A5 (cg-RX-API-DMAC7.html)
DD (1) DD124102A5 (cg-RX-API-DMAC7.html)
DE (1) DE2611041A1 (cg-RX-API-DMAC7.html)
DK (1) DK148344C (cg-RX-API-DMAC7.html)
ES (1) ES446075A1 (cg-RX-API-DMAC7.html)
FR (1) FR2304354A1 (cg-RX-API-DMAC7.html)
GB (1) GB1546448A (cg-RX-API-DMAC7.html)
GR (1) GR60341B (cg-RX-API-DMAC7.html)
IE (1) IE43083B1 (cg-RX-API-DMAC7.html)
LU (1) LU74558A1 (cg-RX-API-DMAC7.html)
MC (1) MC1101A1 (cg-RX-API-DMAC7.html)
NL (1) NL190313C (cg-RX-API-DMAC7.html)
NZ (1) NZ180321A (cg-RX-API-DMAC7.html)
PH (1) PH14927A (cg-RX-API-DMAC7.html)
PT (1) PT64907B (cg-RX-API-DMAC7.html)
SE (1) SE433804B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
CZ286723B6 (cs) * 1991-01-30 2000-06-14 The Wellcome Foundation Limited Tablety dispergovatelné ve vodě
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE69226950T2 (de) * 1991-04-08 1999-05-12 Nippon Shinyaku Co., Ltd., Kyoto Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt
DK0632720T3 (da) * 1992-03-25 1999-07-26 Depomed Inc Hydroxyethylcellulosebaserede depotpræparat-doseringsformer
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CN1108150C (zh) * 1994-05-13 2003-05-14 史密丝克莱恩比彻姆公司 增加钙摄取的方法及所用的制剂
CN1172429A (zh) * 1994-12-01 1998-02-04 希博斯药物公司 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (cg-RX-API-DMAC7.html) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
GR60341B (en) 1978-05-17
DD124102A5 (cg-RX-API-DMAC7.html) 1977-02-02
PH14927A (en) 1982-01-29
DE2611041C2 (cg-RX-API-DMAC7.html) 1988-06-09
NL190313C (nl) 1994-01-17
AU1204976A (en) 1977-09-22
PT64907A (fr) 1976-04-01
LU74558A1 (cg-RX-API-DMAC7.html) 1977-09-27
AU505355B2 (en) 1979-11-15
JPS51115910A (en) 1976-10-13
DE2611041A1 (de) 1976-10-14
DK148344B (da) 1985-06-17
NZ180321A (en) 1978-06-20
NL7602776A (nl) 1976-09-21
AT353415B (de) 1979-11-12
AR222624A1 (es) 1981-06-15
DK148344C (da) 1985-11-04
GB1546448A (en) 1979-05-23
IE43083B1 (en) 1980-12-17
ES446075A1 (es) 1977-09-16
DK113676A (da) 1976-09-18
JPS638084B2 (cg-RX-API-DMAC7.html) 1988-02-19
NL190313B (nl) 1993-08-16
SE433804B (sv) 1984-06-18
CH630257A5 (en) 1982-06-15
IE43083L (en) 1976-09-17
MC1101A1 (fr) 1977-02-04
PT64907B (fr) 1978-03-24
ATA192276A (de) 1979-04-15
CA1073358A (en) 1980-03-11
SE7603325L (sv) 1976-09-18
FR2304354A1 (fr) 1976-10-15

Similar Documents

Publication Publication Date Title
FR2304354B1 (cg-RX-API-DMAC7.html)
JPS5252844U (cg-RX-API-DMAC7.html)
JPS5421636B2 (cg-RX-API-DMAC7.html)
JPS51139818U (cg-RX-API-DMAC7.html)
JPS5222137U (cg-RX-API-DMAC7.html)
JPS5239344Y2 (cg-RX-API-DMAC7.html)
JPS5623413B2 (cg-RX-API-DMAC7.html)
JPS5518315B2 (cg-RX-API-DMAC7.html)
JPS5198781U (cg-RX-API-DMAC7.html)
CH1279675A4 (cg-RX-API-DMAC7.html)
CH595131A5 (cg-RX-API-DMAC7.html)
CH602870A5 (cg-RX-API-DMAC7.html)
CH591948A5 (cg-RX-API-DMAC7.html)
CH591249A5 (cg-RX-API-DMAC7.html)
CH593139A5 (cg-RX-API-DMAC7.html)
CH590127A5 (cg-RX-API-DMAC7.html)
CH589491A5 (cg-RX-API-DMAC7.html)
CH593434A5 (cg-RX-API-DMAC7.html)
CH588987A5 (cg-RX-API-DMAC7.html)
CH577919A5 (cg-RX-API-DMAC7.html)
CH593670A5 (cg-RX-API-DMAC7.html)
CH607111A5 (cg-RX-API-DMAC7.html)
CH603028A5 (cg-RX-API-DMAC7.html)
BG23147A1 (cg-RX-API-DMAC7.html)
BG22920A1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0123, 920430

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0123, 760315

CL Concession to grant licences